Latest News

Air pollution is clearly underestimated as a health hazard, notwithstanding the heated discussion about diesel cars, nitrogen oxides and fine particulate matter. A team of scientists headed by Professor Jos Lelieveld of the Max Planck Institute for Chemistry and Professor Thomas...

Atrial fibrillation can be correctly detected using commercially available smartwatches. This is the conclusion of a study by researchers of the German Centre for Cardiovascular Research (DZHK) at the University Medicine Greifswald and researchers from the Basel University...

Scientists at the German Centre for Cardiovascular Research (DZHK), the University of Greifswald and the TU Dresden have developed a new way to identify different types of immune cells, without using the standard, complex process known as ‘labelling’. The method can identify...

Using state-of-the-art gene analysis, a German research team was able to show that a complex form of congenital heart disease is caused by alterations in several genes and demonstrate how these genetic variations interact. For many years, the team investigated 12 people, from a...

Members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) have decoded a mechanism, how specific intestinal microbiota exacerbate inflammatory diseases at other body sites, such as the lungs. The lung tissue used for the study comes from the...

A new study by DZHK researchers from LMU Munich shows that the protein ApoE plays a key role in the pathogenesis of diseases associated with chronic inflammation, and identifies a new target for therapeutic strategies against atherosclerosis and Alzheimer’s disease.

5,000 patients are currently participating in the clinical trials of the German Centre for Cardiovascular Research (DZHK). The DZHK aims to use these studies to develop new therapies for cardiac failure, heart attacks and atrial fibrillation. Patients participating in clinical...

Exercise programmes for diabetics are a cost effective treatment and should be reimbursed.

Scientists from the German Centre for Cardiovascular Research (DZHK) at the University Hospital Hamburg-Eppendorf (UKE) have found that the use of the Impella heart pump does not reduce the number of deaths in people with cardiogenic shock after a heart attack. This is the result...

Faculty of Medicine and UKSH Kiel receive 1.4 million Euros research funding from the EU